iSAM Funds UK Ltd Acquires New Position in McKesson Co. (NYSE:MCK)

iSAM Funds UK Ltd acquired a new stake in McKesson Co. (NYSE:MCK - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 962 shares of the company's stock, valued at approximately $548,000.

Several other large investors have also recently bought and sold shares of MCK. Millstone Evans Group LLC bought a new stake in McKesson in the fourth quarter valued at approximately $28,000. Synergy Asset Management LLC bought a new stake in McKesson in the fourth quarter valued at approximately $32,000. Crews Bank & Trust bought a new stake in McKesson in the fourth quarter valued at approximately $33,000. Atala Financial Inc bought a new stake in McKesson in the fourth quarter valued at approximately $34,000. Finally, Graney & King LLC bought a new stake in McKesson in the fourth quarter valued at approximately $38,000. Institutional investors own 85.07% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on MCK shares. Wells Fargo & Company upped their target price on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research note on Friday, March 14th. Mizuho upped their target price on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research note on Thursday, April 3rd. Cfra Research downgraded shares of McKesson from a "moderate buy" rating to a "hold" rating in a research report on Friday, April 4th. Evercore ISI increased their price objective on shares of McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Finally, Bank of America increased their price objective on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, McKesson presently has a consensus rating of "Moderate Buy" and an average target price of $686.69.

McKesson Trading Up 0.3%

McKesson stock opened at $726.05 on Tuesday. The company has a market cap of $90.84 billion, a P/E ratio of 33.24, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $728.48. The company has a fifty day simple moving average of $684.84 and a 200 day simple moving average of $629.90.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to the consensus estimate of $94 billion. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm's revenue for the quarter was up 18.9% compared to the same quarter last year. During the same quarter last year, the firm earned $6.18 earnings per share. On average, equities research analysts forecast that McKesson Co. will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Monday, June 2nd. McKesson's dividend payout ratio is currently 10.99%.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares in the company, valued at $36,276,465.36. This trade represents a 12.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.11% of the company's stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.